Cargando…
Metformin requires 4E-BPs to induce apoptosis and repress translation of Mcl-1 in hepatocellular carcinoma cells
Metformin inhibits the mammalian target of rapamycin complex 1 (mTORC1) signaling pathway, which is frequently upregulated in hepatocellular carcinoma (HCC). Metformin has also been shown to induce apoptosis in this cancer. Here, we investigate whether metformin-induced apoptosis in HCC is mediated...
Autores principales: | Bhat, Mamatha, Yanagiya, Akiko, Graber, Tyson, Razumilava, Nataliya, Bronk, Steve, Zammit, Domenick, Zhao, Yunhao, Zakaria, Chadi, Metrakos, Peter, Pollak, Michael, Sonenberg, Nahum, Gores, Gregory, Jaramillo, Maritza, Morita, Masahiro, Alain, Tommy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5584165/ https://www.ncbi.nlm.nih.gov/pubmed/28881582 http://dx.doi.org/10.18632/oncotarget.10671 |
Ejemplares similares
-
Transcriptional profiling of macrophages reveals distinct parasite stage-driven signatures during early infection by Leishmania donovani
por: Chaparro, Visnu, et al.
Publicado: (2022) -
Active-site mTOR inhibitors augment HSV1-dICP0 infection in cancer cells via dysregulated eIF4E/4E-BP axis
por: Zakaria, Chadi, et al.
Publicado: (2018) -
The rate of protein synthesis in hematopoietic stem cells is limited partly by 4E-BPs
por: Signer, Robert A.J., et al.
Publicado: (2016) -
One-Loop BPS amplitudes as BPS-state sums
por: Angelantonj, Carlo, et al.
Publicado: (2012) -
mTOR inhibitor efficacy is determined by the eIF4E/4E-BP ratio
por: Alain, Tommy, et al.
Publicado: (2012)